跳到正文
← 返回论文列表与筛选
阅读说明

本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。

DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。

本页为预印本版本;arXiv 收录、作者填写的期刊信息以及作者既有发表经历,都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对,只展示已核实例,档案仍可能误合并。

引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。

关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。

分类依据与纠错

AI 根据所提供的论文材料归类:摘要研究生存分析中Cox模型的变点选择,未涉及宏观时间序列,所列细分中没有直接对应方向。

反馈分类问题

正在核对关联版本…

代码、数据与补充材料

正在核对对应版本的资源…

关注这篇论文的作者
Ryoto Ozaki
Yoshiyuki Ninomiya

Cox比例风险模型变点检测的信息准则

研究问题
当治疗效应延迟出现、风险比可能发生突变时,如何为带变点的Cox模型选择结构,并处理常规AIC惩罚不足的问题?
方法与思路
作者针对变点模型的非正则性建立偏似然估计的专门渐近理论,再依据AIC的原始推导构造信息准则。
材料陈述的贡献
摘要称得到显式且可能远大于两倍参数数目的惩罚项,并以数值实验和临床试验说明其与形式化AIC的差异。
阅读关注点
应核对变点及风险比的参数化方式、偏似然渐近条件、惩罚项推导,以及候选结构与模型选择目标的定义。
阅读边界
这是预印本,同行评审未核验;摘要未给出惩罚公式、变点间隔要求或数值结果,不能据此确认普遍的选择优势。

原文摘要

The Cox proportional hazards model, commonly used in clinical trials, assumes proportional hazards. However, it does not hold when, for example, there is a delayed onset of the treatment effect. In such a situation, an acute change in the hazard ratio function is expected to exist. This paper considers the Cox model with change-points and derives AIC-type information criteria for detecting those change-points. The change-point model does not allow for conventional statistical asymptotics due to its irregularity, thus a formal AIC that penalizes twice the number of parameters would not be analytically derived, and using it would clearly give overfitting analysis results. Therefore, we will construct specific asymptotics using the partial likelihood estimation method in the Cox model with change-points. Based on the original derivation method for AIC, we propose information criteria that are mathematically guaranteed. If the partial likelihood is used in the estimation, information criteria with penalties much larger than twice the number of parameters could be obtained in an explicit form. Numerical experiments confirm that the proposed criterion is clearly superior in terms of the original purpose of AIC, which is to provide an estimate that is close to the true structure. We also apply the proposed criterion to actual clinical trial data to indicate that it will easily lead to different results from the formal AIC.

笔记与分组
相关领域论文